Literature DB >> 11477546

Modulation of proteinase-K resistant prion protein by prion peptide immunization.

L Souan1, Y Tal, Y Felling, I R Cohen, A Taraboulos, F Mor.   

Abstract

Prion diseases are caused by conformational alterations in the prion protein (PrP). The immune system has been assumed to be non-responsive to the self-prion protein, therefore, PrP autoimmunity has not been investigated. Here, we immunized various strains of mice with PrP peptides, some selected to fit the MHC class II-peptide binding motif. We found that specific PrP peptides elicited strong immune responses in NOD, C57BL/6 and A/J mice. To test the functional effect of this immunization, we examined the expression of proteinase-K-resistant PrP by a scrapie-infected tumor transplanted to immunized syngeneic A/J mice. PrP peptide vaccination did not affect the growth of the infected tumor transplant, but significantly reduced the level of protease-resistant PrP. Our results demonstrate that self-PrP peptides are immunogenic in mice and suggest that this immune response might affect PrP-scrapie levels in certain conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477546     DOI: 10.1002/1521-4141(200108)31:8<2338::aid-immu2338>3.0.co;2-v

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro.

Authors:  Katarina M Luhr; Robert P A Wallin; Hans-Gustaf Ljunggren; Peter Löw; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.

Authors:  Daphne Nikles; Patricia Bach; Klaus Boller; Christoph A Merten; Fabio Montrasio; Frank L Heppner; Adriano Aguzzi; Klaus Cichutek; Ulrich Kalinke; Christian J Buchholz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 4.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

5.  Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells.

Authors:  Katarina M Luhr; Elin K Nordström; Peter Löw; Hans-Gustaf Ljunggren; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection.

Authors:  Magdalini Polymenidou; Frank L Heppner; Erica C Pellicioli; Eduard Urich; Gino Miele; Nathalie Braun; Franziska Wopfner; Hermann M Schätzl; Burkhard Becher; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

7.  Immunization delays the onset of prion disease in mice.

Authors:  Einar M Sigurdsson; David R Brown; Maki Daniels; Richard J Kascsak; Regina Kascsak; Richard Carp; Harry C Meeker; Blas Frangione; Thomas Wisniewski
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

8.  Multiple antigenic peptides facilitate generation of anti-prion antibodies.

Authors:  J Bainbridge; N Jones; B Walker
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

9.  Cell mediated immune responses against human prion protein.

Authors:  J Bainbridge; B Walker
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.